OBJECTIVE: To determine the risk factors—especially the effects of thrombocytosis—for
permanent visual loss in patients with temporal arteritis. METHODS: One hundred seventy-four …

OBJECTIVE: To determine the frequency of occurrence of malignancy concurrently with
temporal arteritis (TA), as well as features and outcome of the vasculitis in such cases. …

… 1 , Jean-François Cadranel, Georges Bonnemaison, Marc Bourlière, Laurence Chiche,
Hélène Chor, Marie-Hélène Denninger, Françoise Degos, Emmanuel Jacquemin, Brigitte …

Background & Aims In phase III trials, the safety profile of triple therapy (pegylated interferon/ribavirin
with boceprevir or telaprevir) seems to be similar in HCV treatment-experienced …

In the years following the identification and advancement of hepatitis C virus (HCV) serum
assay tests, extrahepatic manifestations associated with chronic infections were described, …

Highly active antiretroviral therapy (HAART) in HIV patients generally increases the CD4
cell count, but the level of CD4 cell restoration remains very heterogeneous. IL-7 is the main …

Background Although direct-acting antivirals have been used extensively to treat patients
with chronic hepatitis C virus (HCV) infection, their clinical effectiveness has not been well …

Background Patients with cirrhosis resulting from chronic hepatitis C virus (HCV) infection
are at risk of life-threatening complications, but consistently achieve lower sustained …

Objective To identify potential risk factors and the yield of routine screens for early detection
of malignancy associated with dermatomyositis (DM) and polymyositis (PM). Design …

Background & Aims HDV infection causes severe chronic liver disease in individuals infected
with HBV. However, the factors associated with poor prognosis are largely unknown. Thus, …